Nerandomilast significantly slowed lung function decline in fibrotic lung diseases, showing potential as a new therapeutic option alongside existing antifibrotic therapies. Mepolizumab reduced COPD ...
Sandeep Sahay, MD, FCCP, director of the Pulmonary Hypertension Program, Houston Methodist Hospital, previews key topics of this year's American Thoracic Society (ATS) conference. This year, the ...
Please provide your email address to receive an email when new articles are posted on . ATS 2025 keynote series topics include caring for unhoused individuals and genetic therapy development. ATS put ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results